TLR4 accelerates the progression of atherosclerosis and increases the expression of ICAM-1 and VCAM-1, leading to the synergistic activation of NF-κB in vascular walls in vivo and vascular smooth muscle cells in vitro (Shinohara et al., 2007). The gene discussed is TLR4; the disease is atherosclerosis.